Boston Trust Walden Corp Novo Nordisk A S Transaction History

Boston Trust Walden Corp

$14.1 Billion
Q3 2024

A detailed history of Boston Trust Walden Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Boston Trust Walden Corp holds 5,366 shares of NVO stock, worth $456,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,366

Previous 5,366 -0.0%

Holding current value

$456,110

Previous $765,000 16.6%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$102.11 - $135.92 $1.43 Million - $1.9 Million	-13,980 Reduced 72.26%	5,366 $688,000
Q3 2023 Oct 18, 2023	BUY	$90.94 - $199.54 $879,662 - $1.93 Million	9,673 Added 100.0%	19,346 $1.76 Million
Q2 2023 Jul 24, 2023	BUY	$155.98 - $172.65 $77,990 - $86,325	500 Added 5.45%	9,673 $1.57 Million
Q1 2023 Apr 19, 2023	SELL	$132.34 - $159.14 $26,468 - $31,827	-200 Reduced 2.13%	9,173 $1.46 Million
Q4 2022 Jan 20, 2023	SELL	$102.55 - $135.33 $9,434 - $12,450	-92 Reduced 0.97%	9,373 $0
Q2 2022 Jul 22, 2022	SELL	$103.24 - $121.81 $5,162 - $6,090	-50 Reduced 0.53%	9,465 $1.06 Million
Q1 2022 Apr 20, 2022	SELL	$93.1 - $112.54 $4,655 - $5,627	-50 Reduced 0.52%	9,515 $1.06 Million
Q4 2021 Jan 21, 2022	SELL	$95.88 - $117.08 $4,794 - $5,854	-50 Reduced 0.52%	9,565 $1.07 Million
Q3 2021 Oct 25, 2021	BUY	$84.42 - $106.62 $46,431 - $58,641	550 Added 6.07%	9,615 $923,000
Q2 2021 Jul 22, 2021	BUY	$67.66 - $84.76 $8,457 - $10,595	125 Added 1.4%	9,065 $759,000
Q1 2021 Apr 21, 2021	BUY	$67.06 - $75.82 $18,441 - $20,850	275 Added 3.17%	8,940 $603,000
Q1 2020 Apr 21, 2020	SELL	$49.46 - $64.78 $4,698 - $6,154	-95 Reduced 1.08%	8,665 $522,000
Q4 2019 Jan 10, 2020	BUY	$49.86 - $58.26 $54,596 - $63,794	1,095 Added 14.29%	8,760 $507,000
Q1 2019 Apr 16, 2019	SELL	$46.36 - $52.63 $1,622 - $1,842	-35 Reduced 0.45%	7,665 $401,000
Q4 2018 Jan 17, 2019	SELL	$41.54 - $47.25 $69,579 - $79,143	-1,675 Reduced 17.87%	7,700 $355,000
Q2 2018 Jul 25, 2018	SELL	$44.29 - $50.42 $19,930 - $22,689	-450 Reduced 4.58%	9,375 $432,000
Q1 2018 Apr 13, 2018	BUY	$48.49 - $58.14 $77,584 - $93,024	1,600 Added 19.45%	9,825 $484,000
Q4 2017 Jan 29, 2018	BUY	$47.53 - $53.73 $390,934 - $441,929	8,225	8,225 $441,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Novo Nordisk A S Transaction History